We aimed to review cases of Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT) characterized by neurological sequelae following acute lithium toxicity and to explore whether cerebellar sequelae are more frequent in cases presenting with fever and/or infection.Areas covered: Case reports were identified from: (i) 6 reviews published up to 2005; (ii) MEDLINE, Web of Sciences, Cochrane Library and PsycINFO search.Expert opinion: We identified 123 SILENT cases published from 1965 to 2019, in which cerebellar sequelae were observed in an overwhelming proportion (79%). SILENT may occur at any time during lithium treatment. This complication is most frequently observed during routine lithium treatment, with fewer than 10% of cases...
Introduction. In the history of his usage, by the 1850`s, Lithium was first used for the treatment o...
National audienceAcute Lithium Intoxications, Review of the Literature and Cases Study. The efficacy...
Lithium is an effective first-line mood stabiliser for bipolar disorder, treatment-refractory depres...
Lithium can have toxic effects on the central nervous system (CNS) that can be both acute and chroni...
We report the case of a 31-year-old man with bipolar disorder who was on a combination therapy of li...
Background. Lithium is still the first-line agent for bipolar disorder. Despite common knowledge on ...
WOS: 000323600800019Lithium is one of the first choice agents for long-term prophylaxis and the trea...
Background: Lithium-induced neurotoxicity typically occurs with chronic accumulation rather than fol...
Lithium is an efficacious agent for the treatment of bipolar disorder, but it is unclear to what ext...
Abstract Lithium has been used in the treatment of bipolar affective disorder (BAD) for more than 50...
Lithium is one of the first choice agents for long-term prophylaxis and the treatment of acute episo...
Lithium is a commonly prescribed treatment for bipolar affective disorder. However, treatment is com...
By contrast to the permanent cerebellar sequelae developing over the weeks following a lithium intox...
Introduction. Lithium is considered a first-line therapy for both the acute phase and the maintenanc...
This was a study of a 33-year-old man with bipolar disorder treated with lithium who developed cereb...
Introduction. In the history of his usage, by the 1850`s, Lithium was first used for the treatment o...
National audienceAcute Lithium Intoxications, Review of the Literature and Cases Study. The efficacy...
Lithium is an effective first-line mood stabiliser for bipolar disorder, treatment-refractory depres...
Lithium can have toxic effects on the central nervous system (CNS) that can be both acute and chroni...
We report the case of a 31-year-old man with bipolar disorder who was on a combination therapy of li...
Background. Lithium is still the first-line agent for bipolar disorder. Despite common knowledge on ...
WOS: 000323600800019Lithium is one of the first choice agents for long-term prophylaxis and the trea...
Background: Lithium-induced neurotoxicity typically occurs with chronic accumulation rather than fol...
Lithium is an efficacious agent for the treatment of bipolar disorder, but it is unclear to what ext...
Abstract Lithium has been used in the treatment of bipolar affective disorder (BAD) for more than 50...
Lithium is one of the first choice agents for long-term prophylaxis and the treatment of acute episo...
Lithium is a commonly prescribed treatment for bipolar affective disorder. However, treatment is com...
By contrast to the permanent cerebellar sequelae developing over the weeks following a lithium intox...
Introduction. Lithium is considered a first-line therapy for both the acute phase and the maintenanc...
This was a study of a 33-year-old man with bipolar disorder treated with lithium who developed cereb...
Introduction. In the history of his usage, by the 1850`s, Lithium was first used for the treatment o...
National audienceAcute Lithium Intoxications, Review of the Literature and Cases Study. The efficacy...
Lithium is an effective first-line mood stabiliser for bipolar disorder, treatment-refractory depres...